Cardiorespiratory fitness decreases the odds for subclinical carotid plaques in apolipoprotein e4 homozygotes

Perez-Lasierra, Jose Luis ; Casajús, José A. ; Gonzalez-Agüero, Alejandro ; Arbones-Mainar, José Miguel ; Casasnovas, José A. ; Laclaustra, Martin ; Moreno-Franco, Belén

Resumen: Some studies suggest that being an apolipoprotein e4 (APOE e4) carrier increases the risk of atherosclerosis, and others suggest that cardiorespiratory fitness (CRF) could play a key role in atherosclerotic prevention. Our aim was to analyze the association of APOE e4 with carotid atherosclerosis and the association of CRF with atherosclerosis in APOE e4 carriers. A cross-sectional analysis based on a subsample of 90 participants in the Aragon Workers’ Health Study was carried out. Ultrasonography was used to assess the presence of plaques in carotid territory; the submaximal Chester Step Test was used to assess CRF; and behavioral, demographic, anthropometric, and clinical data were obtained by trained personnel during annual medical examinations. APOE e4e4 participants were categorized into Low-CRF (VO2max <= 35 mL/kg/min) and High-CRF (VO2max ≥ 35 mL/kg/min) groups. After adjusting for several confounders, compared with APOE e3e3, those participants genotyped as APOE e3e4 and APOE e4e4 showed an OR = 1.60 (95% CI 0.45, 5.71) and OR = 4.29 (95% CI 1.16, 15.91), respectively, for carotid atherosclerosis. Compared to Low-CRF APOE e4e4 carriers, the odds of carotid plaque detection were 0.09 (95% CI 0.008, 0.98) times lower among High-CRF APOE e4e4 carriers. The APOE e4e4 genotype was associated with increased carotid atherosclerosis. However, CRF is a modifiable factor that may be targeted by APOE e4e4 to decrease the elevation of atherosclerotic risk due to this genetic condition.

Idioma: Inglés

DOI: 10.1038/s41598-022-23075-2

Año: 2022

Publicado en: Scientific reports (Nature Publishing Group) 12, 1 (2022), 19496 [7 pp.]
ISSN: 2045-2322

Factor impacto JCR: 4.6 (2022)

Categ. JCR: MULTIDISCIPLINARY SCIENCES rank: 22 / 73 = 0.301 (2022) - Q2 - T1

Factor impacto CITESCORE: 7.5 - General (Q1)

Factor impacto SCIMAGO: 0.973 - Multidisciplinary (Q1)

Financiación: info:eu-repo/grantAgreement/ES/DGA/B12-20R
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI19-00948
Financiación: info:eu-repo/grantAgreement/ES/MECD/FPU16-02539

Tipo y forma: Artículo (Versión definitiva)